| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |